| 3/20/2025 | BKHY | S&P puts GCI on negative watch
|
| 3/22/2023 | BKHY | S&P boosts GCI
|
| 9/21/2021 | BKHY | Moody's upgrades GCI
|
| 3/19/2021 | BKHY | S&P ups GCI, cuts unsecured notes
|
| 9/24/2020 | HY | Market Commentary: Two junk deals price; Carvana lags; QTS, Centene, GCI flat; funds lose $4.22 billion
|
| 9/24/2020 | CLHY | Market Commentary: Global Medical, EFS Cogen, Allegro, GCI break; PCI, ASP Navigate, Barrette, Hyland revised
|
| 9/23/2020 | CLHY | Market Commentary: Omnitracs breaks; Ellucian, Vistra, Global Medical, GCI, Allegro, Agiliti changes emerge
|
| 9/23/2020 | BKHY | Moody’s assigns GCI notes B3
|
| 9/23/2020 | HY | New Issue: GCI prices upsized $600 million eight-year notes at par to yield 4¾%
|
| 9/23/2020 | BKHY | S&P rates GCI notes B
|
| 9/23/2020 | HY | GCI to price $350 million eight-year senior notes on Wednesday; initial guidance in 4¾% area
|
| 9/14/2020 | CLHY | Market Commentary: Shearer’s Foods, Lightpath revised; Delta, Consolidated Communications, ASP, GCI set talk
|
| 9/14/2020 | BKHY | Moody's assigns GCI facility Ba2
|
| 9/14/2020 | BKHY | S&P puts GCI on positive watch
|
| 9/11/2020 | CLHY | Market Commentary: LegalShield breaks atop OID; RCN Grande sets spread; Pactiv reveals price guidance
|
| 6/4/2019 | HY | Market Commentary: Stericycle on tap; U.S. Renal expected; GCI gains continue; Neiman Marcus tanks; Ferroglobe jumps
|
| 6/3/2019 | HY | Market Commentary: Multi-Color, Grubhub on tap; Neiman Marcus, GCI price; Teva in focus, gains; Altice up
|
| 6/3/2019 | BKCVHY | S&P rates GCI notes B
|
| 5/14/2019 | BKCVHY | S&P downgrades GCI
|
| 11/14/2018 | BKCVHY | S&P might downgrade GCI
|
| 3/27/2018 | BKCVHY | S&P rates GCI B, lowers debt
|
